APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycosidases

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glycosidases Industry Growth and Trends Forecast to 2032

4 July 2026113 pages

Choose your research edition.

Industry ResearchGlycosidases Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycosidases Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Glycosidases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycosidases Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycosidases Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Glycosidases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycosidases include Thermo Fisher Scientific, Waters Corporation, Vaupell Holdings, Takara Bio, Sumitomo Bakelite, Shimadzu Analytical, S-BIO, RayBiotech and RandD Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glycosidases market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glycosidases market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycosidases market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycosidases.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glycosidases market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glycosidases Market by Company

Thermo Fisher Scientific

Waters Corporation

Vaupell Holdings

Takara Bio

Sumitomo Bakelite

Shimadzu Analytical

S-BIO

RayBiotech

RandD Systems

PerkinElmer

New England Biolabs

Merck Group

Geno Technology

FUJIFILM Wako Pure Chemical Corporation

Danaher

Cambridge Isotope Laboratories

Bruker

Agilent Technologies

Glycosidases Segment by Type

Endoglycosidase

Exoglycosidase

Glycosidases Segment by Application

Academic Research Institutes

Pharmaceutical And Biotechnology Companies

Others

Glycosidases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycosidases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycosidases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycosidases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycosidases manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glycosidases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Endoglycosidase Table 2. Major Company of Exoglycosidase Table 3. Global Glycosidases Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Glycosidases Sales by Type (2021-2026) & (k units) Table 5. Global Glycosidases Sales Market Share in Volume by Type (2021-2026) Table 6. Global Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 7. Global Glycosidases Sales Market Share in Value by Type (2021-2026) Table 8. Global Glycosidases Price by Type (2021-2026) & (USD/unit) Table 9. Global Glycosidases Sales by Type (2027-2032) & (k units) Table 10. Global Glycosidases Sales Market Share in Volume by Type (2027-2032) Table 11. Global Glycosidases Sales by Type (2027-2032) & (US$ Million) Table 12. Global Glycosidases Sales Market Share in Value by Type (2027-2032) Table 13. Global Glycosidases Price by Type (2027-2032) & (USD/unit) Table 14. North America Glycosidases Sales by Type (2021-2026) & (k units) Table 15. North America Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Glycosidases Sales by Type (2021-2026) & (k units) Table 17. Europe Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Glycosidases Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Glycosidases Sales by Type (2021-2026) & (k units) Table 21. Latin America Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Glycosidases Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Glycosidases Sales by Type (2021-2026) & (US$ Million) Table 24. Glycosidases Industry Trends Table 25. Glycosidases Industry Drivers Table 26. Glycosidases Industry Opportunities and Challenges Table 27. Glycosidases Industry Restraints Table 28. Global Glycosidases Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Glycosidases Revenue Market Share by Company (2021-2026) Table 30. Global Glycosidases Sales by Company (2021-2026) & (k units) Table 31. Global Glycosidases Sales Share by Company (2021-2026) Table 32. Global Glycosidases Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Glycosidases Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glycosidases Major Company Production Sites and Headquarters Table 35. Global Glycosidases Company, Product Type & Application Table 36. Global Glycosidases Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Glycosidases by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glycosidases Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Glycosidases Sales by Region (2021-2026) & (k units) Table 41. Global Glycosidases Sales Market Share in Volume by Region (2021-2026) Table 42. Global Glycosidases Sales by Region (2021-2026) & (US$ Million) Table 43. Global Glycosidases Sales Market Share in Value by Region (2021-2026) Table 44. Global Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Glycosidases Sales by Region (2027-2032) & (k units) Table 46. Global Glycosidases Sales Market Share in Volume by Region (2027-2032) Table 47. Global Glycosidases Sales by Region (2027-2032) & (US$ Million) Table 48. Global Glycosidases Sales Market Share in Value by Region (2027-2032) Table 49. Global Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Glycosidases Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Glycosidases Sales by Application (2021-2026) & (k units) Table 52. Global Glycosidases Sales Market Share in Volume by Application (2021-2026) Table 53. Global Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 54. Global Glycosidases Sales Market Share in Value by Application (2021-2026) Table 55. Global Glycosidases Price by Application (2021-2026) & (USD/unit) Table 56. Global Glycosidases Sales by Application (2027-2032) & (k units) Table 57. Global Glycosidases Sales Market Share in Volume by Application (2027-2032) Table 58. Global Glycosidases Sales by Application (2027-2032) & (US$ Million) Table 59. Global Glycosidases Sales Market Share in Value by Application (2027-2032) Table 60. Global Glycosidases Price by Application (2027-2032) & (USD/unit) Table 61. North America Glycosidases Sales by Application (2021-2026) & (k units) Table 62. North America Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Glycosidases Sales by Application (2021-2026) & (k units) Table 64. Europe Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Glycosidases Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Glycosidases Sales by Application (2021-2026) & (k units) Table 68. Latin America Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Glycosidases Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Glycosidases Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Glycosidases Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Waters Corporation Company Information Table 77. Waters Corporation Business Overview Table 78. Waters Corporation Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Waters Corporation Glycosidases Product Portfolio Table 80. Waters Corporation Recent Development Table 81. Vaupell Holdings Company Information Table 82. Vaupell Holdings Business Overview Table 83. Vaupell Holdings Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Vaupell Holdings Glycosidases Product Portfolio Table 85. Vaupell Holdings Recent Development Table 86. Takara Bio Company Information Table 87. Takara Bio Business Overview Table 88. Takara Bio Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Takara Bio Glycosidases Product Portfolio Table 90. Takara Bio Recent Development Table 91. Sumitomo Bakelite Company Information Table 92. Sumitomo Bakelite Business Overview Table 93. Sumitomo Bakelite Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sumitomo Bakelite Glycosidases Product Portfolio Table 95. Sumitomo Bakelite Recent Development Table 96. Shimadzu Analytical Company Information Table 97. Shimadzu Analytical Business Overview Table 98. Shimadzu Analytical Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shimadzu Analytical Glycosidases Product Portfolio Table 100. Shimadzu Analytical Recent Development Table 101. S-BIO Company Information Table 102. S-BIO Business Overview Table 103. S-BIO Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. S-BIO Glycosidases Product Portfolio Table 105. S-BIO Recent Development Table 106. RayBiotech Company Information Table 107. RayBiotech Business Overview Table 108. RayBiotech Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. RayBiotech Glycosidases Product Portfolio Table 110. RayBiotech Recent Development Table 111. RandD Systems Company Information Table 112. RandD Systems Business Overview Table 113. RandD Systems Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. RandD Systems Glycosidases Product Portfolio Table 115. RandD Systems Recent Development Table 116. PerkinElmer Company Information Table 117. PerkinElmer Business Overview Table 118. PerkinElmer Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. PerkinElmer Glycosidases Product Portfolio Table 120. PerkinElmer Recent Development Table 121. New England Biolabs Company Information Table 122. New England Biolabs Business Overview Table 123. New England Biolabs Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. New England Biolabs Glycosidases Product Portfolio Table 125. New England Biolabs Recent Development Table 126. Merck Group Company Information Table 127. Merck Group Business Overview Table 128. Merck Group Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Merck Group Glycosidases Product Portfolio Table 130. Merck Group Recent Development Table 131. Geno Technology Company Information Table 132. Geno Technology Business Overview Table 133. Geno Technology Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Geno Technology Glycosidases Product Portfolio Table 135. Geno Technology Recent Development Table 136. FUJIFILM Wako Pure Chemical Corporation Company Information Table 137. FUJIFILM Wako Pure Chemical Corporation Business Overview Table 138. FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio Table 140. FUJIFILM Wako Pure Chemical Corporation Recent Development Table 141. Danaher Company Information Table 142. Danaher Business Overview Table 143. Danaher Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Danaher Glycosidases Product Portfolio Table 145. Danaher Recent Development Table 146. Cambridge Isotope Laboratories Company Information Table 147. Cambridge Isotope Laboratories Business Overview Table 148. Cambridge Isotope Laboratories Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Cambridge Isotope Laboratories Glycosidases Product Portfolio Table 150. Cambridge Isotope Laboratories Recent Development Table 151. Bruker Company Information Table 152. Bruker Business Overview Table 153. Bruker Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Bruker Glycosidases Product Portfolio Table 155. Bruker Recent Development Table 156. Agilent Technologies Company Information Table 157. Agilent Technologies Business Overview Table 158. Agilent Technologies Glycosidases Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Agilent Technologies Glycosidases Product Portfolio Table 160. Agilent Technologies Recent Development Table 161. North America Glycosidases Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. North America Glycosidases Sales by Country (2021-2026) & (k units) Table 163. North America Glycosidases Sales Market Share by Country (2021-2026) Table 164. North America Glycosidases Sales Forecast by Country (2027-2032) & (k units) Table 165. North America Glycosidases Sales Market Share Forecast by Country (2027-2032) Table 166. North America Glycosidases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Glycosidases Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Glycosidases Market Share by Country (2021-2026) Table 169. North America Glycosidases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Glycosidases Market Share Forecast by Country (2027-2032) Table 171. Europe Glycosidases Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Europe Glycosidases Sales by Country (2021-2026) & (k units) Table 173. Europe Glycosidases Sales Market Share by Country (2021-2026) Table 174. Europe Glycosidases Sales Forecast by Country (2027-2032) & (k units) Table 175. Europe Glycosidases Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Glycosidases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Glycosidases Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Glycosidases Market Share by Country (2021-2026) Table 179. Europe Glycosidases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Glycosidases Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Glycosidases Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Glycosidases Sales by Country (2021-2026) & (k units) Table 183. Asia-Pacific Glycosidases Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Glycosidases Sales Forecast by Country (2027-2032) & (k units) Table 185. Asia-Pacific Glycosidases Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Glycosidases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Glycosidases Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Glycosidases Market Share by Country (2021-2026) Table 189. Asia-Pacific Glycosidases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Glycosidases Market Share Forecast by Country (2027-2032) Table 191. Latin America Glycosidases Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Latin America Glycosidases Sales by Country (2021-2026) & (k units) Table 193. Latin America Glycosidases Sales Market Share by Country (2021-2026) Table 194. Latin America Glycosidases Sales Forecast by Country (2027-2032) & (k units) Table 195. Latin America Glycosidases Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Glycosidases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Glycosidases Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Glycosidases Market Share by Country (2021-2026) Table 199. Latin America Glycosidases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Glycosidases Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Glycosidases Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Glycosidases Sales by Country (2021-2026) & (k units) Table 203. Middle East and Africa Glycosidases Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Glycosidases Sales Forecast by Country (2027-2032) & (k units) Table 205. Middle East and Africa Glycosidases Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Glycosidases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Glycosidases Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Glycosidases Market Share by Country (2021-2026) Table 209. Middle East and Africa Glycosidases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Glycosidases Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Glycosidases Distributors List Table 214. Glycosidases Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Glycosidases Image Figure 2. Global Glycosidases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycosidases Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycosidases Sales (2021-2032) & (k units) Figure 5. Endoglycosidase Image Figure 6. Global Endoglycosidase Sales YoY Growth (2021-2032) & (k units) Figure 7. Exoglycosidase Image Figure 8. Global Exoglycosidase Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Glycosidases Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Glycosidases Market Share by Type 2025 VS 2032 Figure 11. North America Glycosidases Sales Market Share in Volume by Type in 2025 Figure 12. North America Glycosidases Sales Market Share in Value by Type in 2025 Figure 13. Europe Glycosidases Sales Market Share in Volume by Type in 2025 Figure 14. Europe Glycosidases Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Glycosidases Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Glycosidases Sales Market Share in Value by Type in 2025 Figure 17. Latin America Glycosidases Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Glycosidases Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Glycosidases Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Glycosidases Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Glycosidases Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Academic Research Institutes Image Figure 24. Global Academic Research Institutes Sales YoY Growth (2021-2032) & (k units) Figure 25. Pharmaceutical And Biotechnology Companies Image Figure 26. Global Pharmaceutical And Biotechnology Companies Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Glycosidases Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Glycosidases Market Share by Application 2025 VS 2032 Figure 31. North America Glycosidases Sales Market Share in Volume by Application in 2025 Figure 32. North America Glycosidases Sales Market Share in Value by Application in 2025 Figure 33. Europe Glycosidases Sales Market Share in Volume by Application in 2025 Figure 34. Europe Glycosidases Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Glycosidases Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Glycosidases Sales Market Share in Value by Application in 2025 Figure 37. Latin America Glycosidases Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Glycosidases Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Glycosidases Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Glycosidases Sales Market Share in Value by Application in 2025 Figure 41. North America Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Glycosidases Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Glycosidases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Glycosidases Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Glycosidases Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Glycosidases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Glycosidases Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Glycosidases Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Glycosidases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Glycosidases Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Glycosidases Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Glycosidases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Glycosidases Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Glycosidases Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Glycosidases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Glycosidases Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Glycosidases Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Glycosidases Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Endoglycosidase
  • Exoglycosidase
Applications
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Waters Corporation
  • Vaupell Holdings
  • Takara Bio
  • Sumitomo Bakelite
  • Shimadzu Analytical
  • S-BIO
  • RayBiotech
  • RandD Systems
  • PerkinElmer
  • New England Biolabs
  • Merck Group
  • Geno Technology
  • FUJIFILM Wako Pure Chemical Corporation
  • Danaher
  • Cambridge Isotope Laboratories
  • Bruker
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glycosidases Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glycosidases Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glycosidases Market by Type
  6. 1.3.1 Endoglycosidase
  7. 1.3.2 Exoglycosidase
  8. 1.4 Global Glycosidases Market Size by Type
  9. 1.4.1 Global Glycosidases Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Glycosidases Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Glycosidases Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Glycosidases Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Glycosidases Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Glycosidases Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Glycosidases Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Glycosidases Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glycosidases Industry Trends
  2. 2.2 Glycosidases Industry Drivers
  3. 2.3 Glycosidases Industry Opportunities and Challenges
  4. 2.4 Glycosidases Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glycosidases Revenue (2021-2026)
  2. 3.2 Global Top Players by Glycosidases Sales (2021-2026)
  3. 3.3 Global Top Players by Glycosidases Price (2021-2026)
  4. 3.4 Global Glycosidases Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycosidases Major Company Production Sites & Headquarters
  6. 3.6 Global Glycosidases Company, Product Type & Application
  7. 3.7 Global Glycosidases Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycosidases Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycosidases Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycosidases Tier 1, Tier 2, and Tier 3
4 Glycosidases Regional Status and Outlook
  1. 4.1 Global Glycosidases Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glycosidases Historic Market Size by Region
  3. 4.2.1 Global Glycosidases Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glycosidases Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glycosidases Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glycosidases Forecasted Market Size by Region
  7. 4.3.1 Global Glycosidases Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glycosidases Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glycosidases Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glycosidases by Application
  1. 5.1 Glycosidases Market by Application
  2. 5.1.1 Academic Research Institutes
  3. 5.1.2 Pharmaceutical And Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Glycosidases Market Size by Application
  6. 5.2.1 Global Glycosidases Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Glycosidases Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Glycosidases Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Glycosidases Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Glycosidases Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Glycosidases Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Glycosidases Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Glycosidases Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Glycosidases Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Waters Corporation
  8. 6.2.1 Waters Corporation Company Information
  9. 6.2.2 Waters Corporation Business Overview
  10. 6.2.3 Waters Corporation Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Waters Corporation Glycosidases Product Portfolio
  12. 6.2.5 Waters Corporation Recent Developments
  13. 6.3 Vaupell Holdings
  14. 6.3.1 Vaupell Holdings Company Information
  15. 6.3.2 Vaupell Holdings Business Overview
  16. 6.3.3 Vaupell Holdings Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vaupell Holdings Glycosidases Product Portfolio
  18. 6.3.5 Vaupell Holdings Recent Developments
  19. 6.4 Takara Bio
  20. 6.4.1 Takara Bio Company Information
  21. 6.4.2 Takara Bio Business Overview
  22. 6.4.3 Takara Bio Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takara Bio Glycosidases Product Portfolio
  24. 6.4.5 Takara Bio Recent Developments
  25. 6.5 Sumitomo Bakelite
  26. 6.5.1 Sumitomo Bakelite Company Information
  27. 6.5.2 Sumitomo Bakelite Business Overview
  28. 6.5.3 Sumitomo Bakelite Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sumitomo Bakelite Glycosidases Product Portfolio
  30. 6.5.5 Sumitomo Bakelite Recent Developments
  31. 6.6 Shimadzu Analytical
  32. 6.6.1 Shimadzu Analytical Company Information
  33. 6.6.2 Shimadzu Analytical Business Overview
  34. 6.6.3 Shimadzu Analytical Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shimadzu Analytical Glycosidases Product Portfolio
  36. 6.6.5 Shimadzu Analytical Recent Developments
  37. 6.7 S-BIO
  38. 6.7.1 S-BIO Company Information
  39. 6.7.2 S-BIO Business Overview
  40. 6.7.3 S-BIO Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 S-BIO Glycosidases Product Portfolio
  42. 6.7.5 S-BIO Recent Developments
  43. 6.8 RayBiotech
  44. 6.8.1 RayBiotech Company Information
  45. 6.8.2 RayBiotech Business Overview
  46. 6.8.3 RayBiotech Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 RayBiotech Glycosidases Product Portfolio
  48. 6.8.5 RayBiotech Recent Developments
  49. 6.9 RandD Systems
  50. 6.9.1 RandD Systems Company Information
  51. 6.9.2 RandD Systems Business Overview
  52. 6.9.3 RandD Systems Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 RandD Systems Glycosidases Product Portfolio
  54. 6.9.5 RandD Systems Recent Developments
  55. 6.10 PerkinElmer
  56. 6.10.1 PerkinElmer Company Information
  57. 6.10.2 PerkinElmer Business Overview
  58. 6.10.3 PerkinElmer Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 PerkinElmer Glycosidases Product Portfolio
  60. 6.10.5 PerkinElmer Recent Developments
  61. 6.11 New England Biolabs
  62. 6.11.1 New England Biolabs Company Information
  63. 6.11.2 New England Biolabs Business Overview
  64. 6.11.3 New England Biolabs Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 New England Biolabs Glycosidases Product Portfolio
  66. 6.11.5 New England Biolabs Recent Developments
  67. 6.12 Merck Group
  68. 6.12.1 Merck Group Company Information
  69. 6.12.2 Merck Group Business Overview
  70. 6.12.3 Merck Group Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Group Glycosidases Product Portfolio
  72. 6.12.5 Merck Group Recent Developments
  73. 6.13 Geno Technology
  74. 6.13.1 Geno Technology Company Information
  75. 6.13.2 Geno Technology Business Overview
  76. 6.13.3 Geno Technology Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Geno Technology Glycosidases Product Portfolio
  78. 6.13.5 Geno Technology Recent Developments
  79. 6.14 FUJIFILM Wako Pure Chemical Corporation
  80. 6.14.1 FUJIFILM Wako Pure Chemical Corporation Company Information
  81. 6.14.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
  82. 6.14.3 FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio
  84. 6.14.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
  85. 6.15 Danaher
  86. 6.15.1 Danaher Company Information
  87. 6.15.2 Danaher Business Overview
  88. 6.15.3 Danaher Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Danaher Glycosidases Product Portfolio
  90. 6.15.5 Danaher Recent Developments
  91. 6.16 Cambridge Isotope Laboratories
  92. 6.16.1 Cambridge Isotope Laboratories Company Information
  93. 6.16.2 Cambridge Isotope Laboratories Business Overview
  94. 6.16.3 Cambridge Isotope Laboratories Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Cambridge Isotope Laboratories Glycosidases Product Portfolio
  96. 6.16.5 Cambridge Isotope Laboratories Recent Developments
  97. 6.17 Bruker
  98. 6.17.1 Bruker Company Information
  99. 6.17.2 Bruker Business Overview
  100. 6.17.3 Bruker Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Bruker Glycosidases Product Portfolio
  102. 6.17.5 Bruker Recent Developments
  103. 6.18 Agilent Technologies
  104. 6.18.1 Agilent Technologies Company Information
  105. 6.18.2 Agilent Technologies Business Overview
  106. 6.18.3 Agilent Technologies Glycosidases Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Agilent Technologies Glycosidases Product Portfolio
  108. 6.18.5 Agilent Technologies Recent Developments
7 North America by Country
  1. 7.1 North America Glycosidases Sales by Country
  2. 7.1.1 North America Glycosidases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glycosidases Sales by Country (2021-2026)
  4. 7.1.3 North America Glycosidases Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glycosidases Market Size by Country
  6. 7.2.1 North America Glycosidases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glycosidases Market Size by Country (2021-2026)
  8. 7.2.3 North America Glycosidases Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glycosidases Sales by Country
  2. 8.1.1 Europe Glycosidases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glycosidases Sales by Country (2021-2026)
  4. 8.1.3 Europe Glycosidases Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glycosidases Market Size by Country
  6. 8.2.1 Europe Glycosidases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glycosidases Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glycosidases Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glycosidases Sales by Country
  2. 9.1.1 Asia-Pacific Glycosidases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glycosidases Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glycosidases Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glycosidases Market Size by Country
  6. 9.2.1 Asia-Pacific Glycosidases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glycosidases Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glycosidases Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glycosidases Sales by Country
  2. 10.1.1 South America Glycosidases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glycosidases Sales by Country (2021-2026)
  4. 10.1.3 South America Glycosidases Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glycosidases Market Size by Country
  6. 10.2.1 South America Glycosidases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glycosidases Market Size by Country (2021-2026)
  8. 10.2.3 South America Glycosidases Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glycosidases Sales by Country
  2. 11.1.1 Middle East and Africa Glycosidases Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glycosidases Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glycosidases Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glycosidases Market Size by Country
  6. 11.2.1 Middle East and Africa Glycosidases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glycosidases Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glycosidases Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glycosidases Value Chain Analysis
  2. 12.1.1 Glycosidases Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glycosidases Production Mode & Process
  7. 12.2 Glycosidases Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glycosidases Distributors
  10. 12.2.3 Glycosidases Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst